Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 191 results for "novartis"

Novartis to disband cell & gene therapy unit, 120 jobs to go
Reuters India

Novartis to disband cell & gene therapy unit, 120 jobs to go

ZURICH (Reuters) - Novartis is folding activities of its Cell and Gene Therapy unit into other business and research locations, eliminating 120 positions, the Swiss drugmaker said on Wednesday. The move intensifies a corporate makeover begun this ... Yahoo! Finance, 7 hours ago
Novartis Eliminates Cell & Gene Therapie... Genetic Engineering News, 35 minutes ago

810 images for novartis

Bidness Etc, 10 hours ago
Business Insider, 20 hours ago
PharmaVOICE, 2 days ago
Yahoo! Singapore, 1 day ago
Reuters India, 5 hours ago
Xconomy, 4 hours ago
Investor's Business Daily, 6 hours ago, 13 hours ago
Yahoo! UK and Ireland, 14 hours ago
Reuters India, 1 day ago

Novartis India buyback begins tomorrow

CNBC-TV18’s Varinder Bansal talking about Novartis India which is in focus because its buyback opens tomorrow
 Money Control1 week ago Novartis India to turn ex-date for buyback  Business Line1 month ago Novartis India fixes record date for buyback of shares  Business Standard1 month ago

Stocks in news: TCS, IDBI, Ramco Systems, MCX, Hero Motocorp

Novartis | Jindal Saw | Equitas | Mayur Uniquoters | Infinite Computer Solutions | VKJ Infradevelopers | Sunflag Iron Steel | Ramco Systems | IDBI, Century Plyboards | IIFL Holdings | Vardhman Textiles | Astrazeneca Pharma | Xpro India| Welspun India | Hero ...
 Money Control6 days ago

Board of Novartis India approves resignation of company secretary and compliance officer

July 29, 2016 Last Updated at 10:17 IST
 Business Standard1 month ago Novartis India: Outcome of board meeting  Money Control1 month ago Novartis India to hold board meeting  Business Standard1 month ago Novartis India's board meeting on July 28, 2016  Money Control1 month ago

Novartis India standalone net profit rises 42.95% in the June 2016 quarter

Sales decline 26.16% to Rs 158.62 crore Net profit of Novartis India rose 42.95% to Rs 19.07 crore in the quarter ended June 2016 as against Rs 13.34 crore during the previous quarter ended June 2015. Sales declined 26.16% to Rs 158.62 crore in the quarter ...
 Business Standard1 month ago Novartis India Q1 net at Rs 19 cr  Money Control1 month ago Novartis India Q1 net at Rs 19 crore  Business Standard1 month ago

Pricing dispute hits supply of TB drugs in Pakistan

ISLAMABAD (Reuters) - Swiss pharmaceuticals firm Novartis AG said it has stopped making tuberculosis drugs in Pakistan in a dispute over pricing, prompting fears of a health crisis due to a shortage of drugs in a country with the world's fifth-highest TB ...
 Reuters1 month ago

Colombia to set new price for Novartis cancer drug: minister

Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss company broke down, the health minister said on Thursday. A so-called public interest declaration for imatinib will ...
 Reuters2 months ago Prices of 56 drugs used in curing cancer, BP capped  The Financial Chronicle2 months ago NPPA cuts prices of cancer, diabetes, BP drugs by around 25%  Deccan Herald2 months ago

Novartis Just Got Some Great News in Its Battle for Amgen's Market Share

Amgen amgn just took another big hit from Swiss pharma giant Novartis nvs , which has had the California biotech's formidable drug franchise in its sights for while now. The Food and Drug Administration (FDA) on Wednesday approved Novartis ...
 Fortune4 hours ago

Novartis Taps Biosimilar Experience in Europe to Snag U.S. Sales

Novartis AG, which just won U.S. approval for a lower-priced version of Amgen Inc.'s blockbuster arthritis drug Enbrel, estimates that the market for copies of biotechnology drugs could grow seven-fold by the end of the decade. The treatment, ...
 Bloomberg6 hours ago FDA approves Novartis biosimilar to Amgen's Enbrel  Reuters1 day ago FDA knocks back Novartis copy of Amgen's drug Neulasta  Reuters1 month ago FDA panel supports Novartis version of Amgen arthritis drug  Reuters1 month ago

Novartis commits to CAR-T manufacturing in restructure of cell therapy wo

Novartis has decided to disband its cell and gene therapy unit that has done its initial CAR-T work, a move that means 120 of the 400 workers will be let go and the rest redeployed. But the Swiss drugmaker insists the program is still alive and that ...
 FiercePharma13 minutes ago Breaking: Novartis closing cell therapy unit, but won't quit CAR-T work  MedCity News3 hours ago Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race  Xconomy5 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis
Get updated on latest news & your favorite topics right in your inbox!
More     Less